88 related articles for article (PubMed ID: 16169818)
1. Serum vascular endothelial growth factor as a significant marker of treatment response in pediatric malignancies.
Ben Arush MW; Schenzer P; Maurice S; Elhasid R; Postovsky S; Ben Barak A; Haimi M; Zeidman I; Hayari L; Livne E
Pediatr Hematol Oncol; 2005 Sep; 22(6):513-24. PubMed ID: 16169818
[TBL] [Abstract][Full Text] [Related]
2. Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.
Ben Arush MW; Ben Barak A; Maurice S; Livne E
Pediatr Hematol Oncol; 2007 Mar; 24(2):111-5. PubMed ID: 17454776
[TBL] [Abstract][Full Text] [Related]
3. Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW; Shafat I; Ben Barak A; Shalom RB; Vlodavsky I; Ilan N
Pediatr Hematol Oncol; 2009 Jun; 26(4):157-64. PubMed ID: 19437318
[TBL] [Abstract][Full Text] [Related]
4. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
6. Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission.
Rueda A; Olmos D; Villareal V; Torres E; Pajares BI; Alba E
Clin Lymphoma Myeloma; 2007 May; 7(6):400-5. PubMed ID: 17621405
[TBL] [Abstract][Full Text] [Related]
7. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.
Qian CN; Zhang CQ; Guo X; Hong MH; Cao SM; Mai WY; Min HQ; Zeng YX
Cancer; 2000 Jan; 88(2):255-61. PubMed ID: 10640954
[TBL] [Abstract][Full Text] [Related]
10. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of VEGF and its receptor in refractory leukemia cells.
Wang L; Zhang W; Ding Y; Xiu B; Li P; Dong Y; Zhu Q; Liang A
Int J Clin Exp Pathol; 2015; 8(5):5282-90. PubMed ID: 26191229
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma.
Schiavetti A; McDowell HP; Conti L; Altavista P; Antenucci A; Pizer B; Dominici C
Pediatr Blood Cancer; 2012 Oct; 59(4):627-30. PubMed ID: 22231858
[TBL] [Abstract][Full Text] [Related]
13. VEGF as a biomarker for metastatic uveal melanoma in humans.
Barak V; Pe'er J; Kalickman I; Frenkel S
Curr Eye Res; 2011 Apr; 36(4):386-90. PubMed ID: 21284506
[TBL] [Abstract][Full Text] [Related]
14. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
15. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
Aw MM; Mitry RR; Hughes RD; Dhawan A
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
[TBL] [Abstract][Full Text] [Related]
20. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
